Endonovo Therapeutics Market Cap

Endonovo Therapeutics has a market cap or net worth of $90.38 thousand as of April 29, 2026. Its market cap has decreased by -63.07% in one year.

Market Cap

90.38K

Enterprise Value

n/a

Revenue

255.72K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since February 20, 2013, Endonovo Therapeutics's market cap has increased from 78.90K to 90.38K, an increase of 14.55%. That is a compound annual growth rate of 1.04%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	90.38K	-50.00%
Dec 31, 2025	180.76K	-16.91%
Dec 31, 2024	217.55K	-92.16%
Dec 29, 2023	2.77M	-20.72%
Dec 30, 2022	3.50M	211.37%
Dec 31, 2021	1.12M	127.79%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Regen BioPharma	201.47K
GB Sciences	158.82K
Innovation Pharmaceuticals	158.63K
Helix BioMedix	224.71K
Lipella Pharmaceuticals	141.86K
Scorpius Holdings	128.40K
Sigyn Therapeutics	123.33K
Immunotech Laboratories	114.99K

Market Cap Rankings